AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

IDXX · NASDAQ · Medical - Diagnostics & Research

IDEXX Laboratories (IDXX)

Provides veterinary diagnostics, reference laboratories, and practice software for connected clinical workflows.

$520.00

vs last close−1.50 (−0.29%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	916	902	964	1,004	976	954	998	1,109	1,105	1,091	1,141	1,217
Cost of revenue	368	375	371	383	380	384	375	415	422	432	418	437
Gross profit	548	526	593	621	596	571	623	695	683	658	723	779
	273	281	294	355	292	309	307	322	329	343	360	354
Research & development	48	52	53	55	54	58	59	62	63	67	66	65
	225	229	241	300	238	251	248	260	265	276	294	288
Selling & marketing	136	142	149	143	146	150	156	161	159	167	175	171
General & administrative	89	87	92	157	92	101	92	99	106	109	119	117
Operating income	275	245	299	264	304	262	317	373	355	316	363	426
	−7	−6	−3	−5	−5	−5	−6	−11	−10	−9	−7	−8
Interest income	1	4	4	3	3	2	1	1	1	1	1	1
Interest expense	9	9	8	8	8	7	8	11	11	11	8	10
Other non-operating income	−1	−4	−4	−3	−3	−2	−1	−1	−1	−2	−1	−2
Income before tax	268	240	295	259	299	256	310	362	345	307	355	417
Income tax expense	56	45	60	56	66	40	67	68	70	59	77	79
Net income from continuing operations	212	195	236	203	233	216	243	294	275	248	278	338
Net income	212	195	236	203	233	216	243	294	275	248	278	338
EPS, basic	$2.55	$2.34	$2.84	$2.46	$2.83	$2.63	$2.98	$3.66	$3.43	$3.10	$3.48	$4.23
EPS, diluted	$2.53	$2.32	$2.81	$2.44	$2.80	$2.62	$2.96	$3.63	$3.40	$3.08	$3.45	$4.19
Weighted average shares, basic	83	83	83	83	82	82	81	80	80	80	80	80
Weighted average shares, diluted	84	84	84	83	83	83	82	81	81	81	81	81
EBITDA	306	279	335	301	342	299	352	409	392	356	401	468
Depreciation & amortization	29	30	30	32	34	34	34	36	37	39	38	41
EBIT	277	249	303	267	307	265	318	374	355	317	363	427